Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Die Ophthalmologie
Erschienen in: Der Ophthalmologe 2/2017

03.02.2017 | Arteriitis temporalis | Leitlinien, Stellungnahmen und Empfehlungen

Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)

Stand November 2016

verfasst von: Deutsche Ophthalmologische Gesellschaft, Retinologische Gesellschaft e. V., Berufsverband der Augenärzte Deutschlands e. V.

Erschienen in: Die Ophthalmologie | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Auszug

Erstellungsdatum: 11/2016 …
Literatur
1.
2.
Fraser SG, Adams W (2009) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 1:CD001989
3.
Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24(4):493–519PubMedCrossRef
4.
5.
Duker JS, Sivalingam A, Brown GC, Reber R (1991) A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 109:339–342PubMedCrossRef
6.
Leavitt JA, Larson TA, Hodge DO, Gullerud RE (2011) The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 152(5):820–823.e2PubMedPubMedCentralCrossRef
7.
Rumelt S, Dorenboim Y, Rehany U (1999) Aggressive systematic treatment for central retinal artery occlusion.(Erratum appears in Am J Ophthalmol 2000 Dec;130(6):908). Am J Ophthalmol 128:733–738PubMedCrossRef
8.
Rudkin AK, Lee AW, Chen CS (2009) Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 16(6):674–677PubMedCrossRef
9.
Karjalainen K (1971) Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol (Copenh) 109:1–96
10.
Brown GC, Magargal LE (1982) Central retinal artery obstruction and visual acuity. Ophthalmology 89:14–19PubMedCrossRef
11.
Hayreh SS (2014) Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 41:1–25PubMedCrossRef
12.
Uhr JH, Mishra K, Wei C, Wu AY (2016) Awareness and knowledge of emergent ophthalmic disease among patients in an internal medicine clinic. JAMA Ophthalmol 134(4):424–431PubMedCrossRef
13.
Schmidt D, Schumacher M, Feltgen N (2009) Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 247:491–494PubMedCrossRef
14.
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 116(10):1928–1936PubMedPubMedCentralCrossRef
15.
Hayreh SS, Zimmerman MB (2007) Fundus Changes in Central Retinal Artery Occlusion. Retina (Philadelphia, Pa) 27:276–289CrossRef
16.
Wong TY, Klein R (2002) Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol 13:142–146PubMedCrossRef
17.
Naumann G (1997) Pathologie des Auges. In: Naumann G (Hrsg) Embryologie, Anatomie und Untersuchungstechnik, 2. Aufl. Bd. 1. Springer, Berlin, S 1008–1012
18.
Hayreh SS, Zimmerman MB (2014) Amaurosis Fugax in ocular vascular occlusive disorders: Prevalence and pathogeneses. Retina (Philadelphia, Pa) 34(1):115–122CrossRef
19.
Petzold A, Islam N, Hu H‑H, Plant GT (2013) Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 58(1):42–62PubMedCrossRef
20.
21.
Ness T, Bley TA, Schmidt WA, Lamprecht P (2013) The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int 110(21):376–385 (quiz 386)PubMedPubMedCentral
22.
Brown GC, Magargal LE (1988) The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 11:239–251PubMedCrossRef
23.
Duker JS, Cohen MS, Brown GC, Sergott RC, McNamara JA (1990) Combined branch retinal artery and central retinal vein obstruction. Retina (Philadelphia, Pa) 10:105–112CrossRef
24.
Chen S‑N, Hwang J‑F, Chen Y‑T (2011) Macular thickness measurements in central retinal artery occlusion by optical coherence tomography. Retina (Philadelphia, Pa) 31(4):730–737CrossRef
25.
Ritter M, Sacu S, Deák GG, Kircher K, Sayegh RG, Pruente C et al (2012) In vivo identification of alteration of inner neurosensory layers in branch retinal artery occlusion. Br J Ophthalmol 96(2):201–207PubMedCrossRef
26.
Schmidt D, Kube T, Feltgen N (2006) Central retinal artery occlusion: findings in optical coherence tomography and functional correlations. Eur J Med Res 11:250–252PubMed
27.
Chu YK, Hong YT, Byeon SH, Kwon OW (2013) In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a „prominent middle limiting membrane sign.“. Retina (Philadelphia, Pa) 33(10):2110–2117CrossRef
28.
Dotan G, Goldenberg D, Kesler A, Naftaliev E, Loewenstein A, Goldstein M (2014) The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy. Ophthalmic Surg Lasers Imaging Retina 45(1):38–44PubMedCrossRef
29.
Brown GC, Magargal LE, Federman JL (1980) Ischaemia and neovascularization. Trans Ophthalmol Soc U K 100:377–380PubMed
30.
Brown GC, Magargal LE, Simeone FA, Goldberg RE, Federman JL, Benson WE (1982) Arterial obstruction and ocular neovascularization. Ophthalmology 89:139–146PubMedCrossRef
31.
Duker JS, Brown GC (1988) Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology 95:1244–1250PubMedCrossRef
32.
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 116(6):1188–1194.e4PubMedPubMedCentralCrossRef
33.
Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140:376–391PubMedCrossRef
34.
Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68(3):318–323PubMedCrossRef
35.
Ball EL, Walsh SR, Tang TY, Gohil R, Clarke JMF (2010) Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 97(12):1765–1771PubMedCrossRef
36.
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122–1128PubMedCrossRef
37.
Murchison AP, Gilbert ME, Bilyk JR, Eagle RC, Pueyo V, Sergott RC et al (2012) Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 154(4):722–729PubMedCrossRef
38.
39.
40.
41.
Rim TH, Han J, Choi YS, Hwang S‑S, Lee CS, Lee SC et al (2016) Retinal artery occlusion and the risk of stroke development: twelve-year nationwide cohort study. Stroke 47(2):376–382PubMedCrossRef
42.
Chang Y‑S, Jan R‑L, Weng S‑F, Wang J‑J, Chio C‑C, Wei F‑T et al (2012) Retinal artery occlusion and the 3‑year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 154(4):645–652.e1PubMedCrossRef
43.
Amarenco P, Lavallée PC, Labreuche J, Albers GW, Bornstein NM, Canhão P et al (2016) One-year risk of stroke after transient Ischemic attack or minor stroke. N Engl J Med 374(16):1533–1542PubMedCrossRef
44.
Park SJ, Choi N‑K, Yang BR, Park KH, Lee J, Jung S‑Y et al (2015) Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology 122(11):2336–2343PubMedCrossRef
45.
Callizo J, Feltgen N, Pantenburg S, Wolf A, Neubauer AS, Jurklies B et al (2015) Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination. Ophthalmology 122(9):1881–1888PubMedCrossRef
46.
Leisser C, Kaufmann TA, Feltgen N, Schumacher M, Schmoor C, Meckel S (2015) Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graefes Arch Clin Exp Ophthalmol 253(8):1227–1230PubMedCrossRef
47.
Rudkin AK, Lee AW, Chen CS (2010) Vascular risk factors for central retinal artery occlusion. Eye 24(4):678–681PubMedCrossRef
48.
Hayreh SS (1971) Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 72:998–1011PubMedCrossRef
49.
Schmidt D, Hetzel A, Geibel-Zehender A, Schulte-Monting J (2007) Systemic diseases in non-inflammatory branch and central retinal artery occlusion – an overview of 416 patients. Eur J Med Res 12:595–603PubMed
50.
Hayreh SS, Kolder HE, Weingeist TA (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87:75–78PubMedCrossRef
51.
Atebara NH, Brown GC, Cater J (1995) Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 102:2029–2034 (discussion 2034–5)PubMedCrossRef
52.
53.
Brown GC (1991) Retinal vascular diseases. J Ophthalmic Nurs Technol 10:71–75PubMed
54.
Mason JO, Shah AA, Vail RS, Nixon PA, Ready EL, Kimble JA (2008) Branch Retinal Artery Occlusion: Visual Prognosis. Am J Ophthalmol 146(3):455–457PubMedCrossRef
55.
Fraser S, Siriwardena D (2002) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 1:CD001989
56.
Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye 27(6):688–697PubMedPubMedCentralCrossRef
57.
Pielen A, Junker B, Hansen L, Agostini H, Feltgen N (2010) Diagnostik und Therapie beim nicht arteriitischen Zentralarterienverschluss. Klin Monbl Augenheilkd 227:712–720PubMedCrossRef
58.
Feltgen N, Schmidt D, Hansen L (2003) Arterielle retinale Verschlusse. Ophthalmologe 100:651–665 (quiz 666–7)PubMedCrossRef
59.
Hollenhorst RW (1961) Significance of bright plaques in the retinal arterioles. Trans Am Ophthalmol Soc 59:252–273PubMedPubMedCentral
60.
Hayreh SS (2007) Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. Graefes Arch Clin Exp Ophthalmol 245:464–466PubMedCrossRef
61.
Noble J, Weizblit N, Baerlocher MO, Eng KT (2008) Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 92:588–593PubMedCrossRef
62.
Fieß A, Cal O, Kehrein S, Halstenberg S, Frisch I, Steinhorst UH (2014) Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy? BMC Ophthalmol 14(1):28PubMedPubMedCentralCrossRef
63.
Barbón-García JJ, Alvarez-Suárez ML (2007) Paracentesis and ocular massage as treatment of central retinal artery occlusion. Arch Soc Esp Oftalmol 82(10):657–659PubMedCrossRef
64.
Mueller A, Neubauer A, Schaller U, Kampik A (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121:1377–1381PubMedCrossRef
65.
66.
Schmidt D (2000) Ocular massage in a case of central retinal artery occlusion the successful treatment of a hitherto undescribed type of embolism. Eur J Med Res 5(4):157–164PubMed
67.
Cope A, Eggert JV, O’Brien E (2011) Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen. Diving Hyperb Med 41(3):135–138PubMed
68.
Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B (2012) Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 153(3):454–459.e2PubMedCrossRef
69.
Aisenbrey S, Krott R, Heller R, Krauss D, Rössler G, Heimann K (2000) Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 97(7):461–467PubMedCrossRef
70.
Weiss JN (2009) Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med 36(6):401–405PubMed
71.
Bertram B, Wolf S, Fisches H, Schulte K, Hoberg A, Reim M (1991) Thrombolytic treatment of retinal arterial occlusions with plasminogen activator. Klin Monbl Augenheilkd 198:295–300PubMedCrossRef
72.
Feltgen N, Schmidt D, Schumacher M (2007) Response to comment: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE-Group) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 245:467–470CrossRef
73.
Deutsche Schlaganfall Gesellschaft. Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke. AWMF-Register Nr. 030-133. 2015.
74.
Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J et al (2006) Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950–956PubMedCrossRef
75.
Beatty S, Au Eong KG (2000) Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 84:914–916PubMedPubMedCentralCrossRef
76.
Hazin R, Dixon JA, Bhatti MT (2009) Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Curr Opin Ophthalmol 20(3):210–218PubMedCrossRef
77.
Vallee JN, Aymard A, Paques M, Santiago PY, Gaudric A, Merland JJ (2001) Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion. J Radiol 82:137–144PubMed
78.
Von Mach M‑A, Güz A, Wiechelt J, Pfeiffer N, Weilemann LS (1946) Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study. Dtsch Med Wochenschr 130(16):1002–1006CrossRef
79.
Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117(7):1367–1375.e1PubMedCrossRef
80.
Chen CS, Lee AW, Campbell B, Lee T, Paine M, Fraser C et al (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 42(8):2229–2234PubMedCrossRef
81.
Hattenbach L‑O, Kuhli-Hattenbach C, Scharrer I, Baatz H (2008) Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146(5):700–706PubMedCrossRef
82.
Schrag M, Youn T, Schindler J, Kirshner H, Greer D (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72(10):1148–1154PubMedCrossRef
83.
Schmidt DP, Schulte-Monting J, Schumacher M (2002) Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 23:1301–1307PubMed
84.
Kiesewetter H, Blume J, Jung F, Spitzer S, Wenzel E (1990) Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb. J Intern Med 227:107–114PubMedCrossRef
85.
Roth S (1992) The effects of isovolumic hemodilution on ocular blood flow. Exp Eye Res 55(1):59–63PubMedCrossRef
86.
Neely KA, Ernest JT, Goldstick TK, Linsenmeier RA, Moss J (1996) Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol 234:688–694PubMedCrossRef
87.
Rüfer F, Schröder A, Winter R, Erb C (2003) Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion. Ophthalmologe 100(10):819–824PubMedCrossRef
88.
Wiederholt M, Leonhardt H, Schmid-Schönbein H, Hager H (1980) Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution. Klin Monbl Augenheilkd 177(2):157–164PubMedCrossRef
89.
Wolf S, Hoberg A, Bertram B, Jung F, Kiesewetter H, Reim M (1989) Video fluorescein angiography follow-up of patients with retinal artery occlusion]. [German. Klin Monatsbl Augenheilkd 195:154–160PubMedCrossRef
90.
Arend O, Hoberg A, Bertram B, Reim M, Wolf S (1991) Hemodilution in acute arterial circulatory disorders of the retina. Acta Med Austriaca 18:66–68PubMed
91.
Diener H‑C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J et al (2016) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. Eur Heart J. doi:10.​1093/​eurheartj/​ehv643
92.
Diener H‑C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J et al (2016) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. Eur Heart J. doi:10.​1093/​eurheartj/​ehw069
93.
94.
Sandercock P, Gubitz G, Foley P, Counsell C (2003) Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000029
95.
Rothwell PM, Algra A, Chen Z, Diener H‑C, Norrving B, Mehta Z (2016) Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 388(10042):365–375PubMedPubMedCentralCrossRef
96.
Frayser R, Saltzman HA, Anderson B, Hickam JB, Sieker HO (1967) The effect of hyperbaric oxygenation on retinal circulation. Arch Ophthalmol 77(2):265–269PubMedCrossRef
97.
Nichols CW, Lambertsen C (1969) Effects of high oxygen pressures on the eye. N Engl J Med 281(1):25–30PubMedCrossRef
98.
Oguz H, Sobaci G (2008) The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 53(2):112–120PubMedCrossRef
99.
Butler FK, Hagan C, Murphy-Lavoie H (2008) Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med 35(5):333–387PubMed
100.
Murphy-Lavoie H, Butler F, Hagan C (2012) Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm. Undersea Hyperb Med 39(5):943–953PubMed
101.
102.
Gaydar V, Ezrachi D, Dratviman-Storobinsky O, Hofstetter S, Avraham-Lubin BCR, Goldenberg-Cohen N (2011) Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment. Invest Ophthalmol Vis Sci 52(10):7514–7522PubMedCrossRef
103.
Christiansen CB, Lip GYH, Lamberts M, Gislason G, Torp-Pedersen C, Olesen JB (2013) Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost 11(8):1485–1492PubMedCrossRef
104.
Cahill MT, Stinnett SS, Fekrat S (2003) Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 136(6):1136–1150PubMedCrossRef
105.
Bertram B, Remky A, Arend O, Wolf S, Reim M (1995) Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 4(6):332–335PubMed
106.
Marcucci R, Sodi A, Giambene B, Liotta AA, Poli D, Mannini L et al (2007) Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis 18(4):321–326PubMedCrossRef
107.
108.
Duker JS, Brown GC (1989) Neovascularization of the optic disc associated with obstruction of the central retinal artery. Ophthalmology 96:87–91PubMedCrossRef
109.
Sivalingam A, Brown GC, Magargal LE (1991) The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 15:15–20PubMedCrossRef
110.
Sivalingam A, Brown GC, Magargal LE, Menduke H (1989) The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol 13:187–191PubMedCrossRef
Metadaten
Titel
Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)
Stand November 2016
verfasst von
Deutsche Ophthalmologische Gesellschaft
Retinologische Gesellschaft e. V.
Berufsverband der Augenärzte Deutschlands e. V.
Publikationsdatum
03.02.2017
Verlag
Springer Medizin
Erschienen in
Die Ophthalmologie / Ausgabe 2/2017
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-016-0435-1

Weitere Artikel der Ausgabe 2/2017

Der Ophthalmologe 2/2017 Zur Ausgabe

Leitthema

Rolle des alternden visuellen Systems bei Glaukomen

Einführung zum Thema

Alterndes visuelles System im Kontext neurodegenerativer Erkrankungen

Bild und Fall

Einseitige Bindehautchemosis mit ödematöser Gesichtsbeteiligung

Kasuistiken

Glaskörpermetastase eines malignen Melanoms der Haut unter Ipilimumab

Das therapeutische Prinzip

Sehverbesserung durch perzeptuelles Lernen bei Refraktionsfehlern und Presbyopie

Leitthema

Retinale Bildgebung von Makula und Papille bei neurodegenerativen Erkrankungen

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Therapieverfahren in der Augenheilkunde CME-Artikel

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Erkrankungen der Hornhaut CME-Artikel

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise